You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 11, September 19, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Malaria
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Tepper and colleagues point out that Canadian troops serving in Afghanistan are now offered alternatives to mefloquine for their malaria chemoprophylaxis in theater. Mefloquine has been associated with serious psychiatric events during travel abroad.1 A recent survey of case reports found that mefloquine has also been associated with 19 deaths in users, including 3 suicides.2 It is therefore reasonable to avoid prescribing a drug with potential serious risks (mefloquine) as first-line prophylaxis against an infection (P vivax malaria) that has low regional endemicity, seasonal transmission, and low lethality.

Space limitations in our article precluded addressing the question of terminal prophylaxis with primaquine, an 8-aminoquinoline that is selectively toxic to the pre-erythrocytic stages (tissue schizonts) of plasmodia in the liver and also kills the hypnozoites of P vivax and Plasmodium ovale.3 Blood schizonticides such as chloroquine and mefloquine will not prevent P vivax and P ovale . . . [Full Text of this Article]

Ashley M. Croft, MD
ashley.croft810@land.mod.uk
Headquarters Fifth Division
Shrewsbury, United Kingdom

Alicia H. Darbyshire, MD
Headquarters International Security Assistance Force
Kabul, Afghanistan

Christopher J. Jackson, MD
Camp Souter
Kabul, Afghanistan

Pieter P. van Thiel, MD
Academic Medical Center
University of Amsterdam
Amsterdam, the Netherlands



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan
Martin Tepper, Steve Schofield, and James Anderson
JAMA. 2007;298(11):1275.
EXTRACT | FULL TEXT  

RELATED ARTICLE

An Outbreak of Malaria in US Army Rangers Returning From Afghanistan
Russ S. Kotwal, Robert B. Wenzel, Raymond A. Sterling, William D. Porter, Nikki N. Jordan, and Bruno P. Petruccelli
JAMA. 2005;293(2):212-216.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.